Castor News | Sep 05, 2024
Castor introduced a new pricing model for Single Sign On (SSO) with a one-time implementation fee and a scalable monthly maintenance fee...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
Castor is a health-tech company based in New York, NY, specializing in providing a comprehensive eClinical data management platform for clinical trials. They focus on making patient-centered clinical trials accessible worldwide by leveraging technology to optimize every aspect of the trial process.
- Castor introduced a new pricing model for Single Sign On (SSO) with a one-time implementation fee and a scalable monthly maintenance fee.
- Castor's Impact Program now includes early stage biotech and medical device companies and research on preventive medicine.
- Castor now follows the OWASP top 10 for vulnerability awareness and conducts yearly penetration tests.
- Castor's number of happy users has decreased from over 5,000 to over 4,000, and the number of countries served has reduced from over 3 to over 2.
- Castor conducted all audits remotely but faced challenges with an in-person requirement for their ISO/SOC2 audit.
Did you find it useful?
If you liked this report, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense AI.